Literature DB >> 10482769

Angiotensin II decreases neuronal delayed rectifier potassium current: role of calcium/calmodulin-dependent protein kinase II.

M Zhu1, C H Gelband, P Posner, C Sumners.   

Abstract

Angiotensin II (Ang II) acts at specific receptors located on neurons in the hypothalamus and brain stem to elicit alterations in blood pressure, fluid intake, and hormone secretion. These actions of Ang II are mediated via Ang II type 1 (AT1) receptors and involve modulation of membrane ionic currents and neuronal activity. In previous studies we utilized neurons cultured from the hypothalamus and brain stem of newborn rats to investigate the AT1 receptor-mediated effects of Ang II on neuronal K+ currents. Our data indicate that Ang II decreases neuronal delayed rectifier (Kv) current, and that this effect is partially due to activation of protein kinase C (PKC), specifically PKCalpha. However, the data also indicated that another Ca2+-dependent mechanism was also involved in addition to PKC. Because Ca2+/calmodulin-dependent protein kinase II (CaM KII) is a known modulator of K+ currents in neurons, we investigated the role of this enzyme in the AT1 receptor-mediated reduction of neuronal Kv current by Ang II. The reduction of neuronal Kv current by Ang II was attenuated by selective inhibition of either calmodulin or CaM KII and was mimicked by intracellular application of activated (autothiophosphorylated) CaM KIIalpha. Concurrent inhibition of CaM KII and PKC completely abolished the reduction of neuronal Kv by Ang II. Consistent with these findings is the demonstration that Ang II increases CaM KII activity in neuronal cultures, as evidenced by increased levels of autophosphorylated CaM KIIalpha subunit. Last, single-cell reverse transcriptase (RT)-PCR analysis revealed the presence of AT1 receptor-, CaM KIIalpha-, and PKCalpha subunit mRNAs in neurons that responded to Ang II with a decrease in Kv current. The present data indicate that the AT1 receptor-mediated reduction of neuronal Kv current by Ang II involves a Ca2+/calmodulin/CaM KII pathway, in addition to the previously documented involvement of PKC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482769     DOI: 10.1152/jn.1999.82.3.1560

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  15 in total

Review 1.  Control of Na+ spike backpropagation by intracellular signaling in the pyramidal neuron dendrites.

Authors:  H Tsubokawa
Journal:  Mol Neurobiol       Date:  2000 Aug-Dec       Impact factor: 5.590

2.  The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase.

Authors:  Erin G Rosenbaugh; James W Roat; Lie Gao; Rui-Fang Yang; Devika S Manickam; Jing-Xiang Yin; Harold D Schultz; Tatiana K Bronich; Elena V Batrakova; Alexander V Kabanov; Irving H Zucker; Matthew C Zimmerman
Journal:  Biomaterials       Date:  2010-04-07       Impact factor: 12.479

3.  Multiscale model of dynamic neuromodulation integrating neuropeptide-induced signaling pathway activity with membrane electrophysiology.

Authors:  Hirenkumar K Makadia; Warren D Anderson; Dirk Fey; Thomas Sauter; James S Schwaber; Rajanikanth Vadigepalli
Journal:  Biophys J       Date:  2015-01-06       Impact factor: 4.033

4.  Apamin-Sensitive Small Conductance Calcium-Activated Potassium Channels were Negatively Regulated by Captopril in Volume-Overload Heart Failure Rats.

Authors:  Bai Hongyuan; Dong Xin; Zhang Jingwen; Gao Li; Ni Yajuan
Journal:  J Membr Biol       Date:  2016-02-29       Impact factor: 1.843

5.  Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration.

Authors:  Krupa Savalia; Devika S Manickam; Erin G Rosenbaugh; Jun Tian; Iman M Ahmad; Alexander V Kabanov; Matthew C Zimmerman
Journal:  Free Radic Biol Med       Date:  2014-06-09       Impact factor: 7.376

6.  Regulation of c-fos, c-jun and c-myc gene expression by angiotensin II in primary cultured rat astrocytes: role of ERK1/2 MAP kinases.

Authors:  Jimmy Delaney; Roselynn Chiarello; David Villar; Umadevi Kandalam; Ana Maria Castejon; Michelle A Clark
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

7.  Effect of intravenous angiotensin II infusion on responses to hypothalamic PVN injection of bicuculline.

Authors:  Lila P LaGrange; Glenn M Toney; Vernon S Bishop
Journal:  Hypertension       Date:  2003-11-03       Impact factor: 10.190

8.  Mitochondria-produced superoxide mediates angiotensin II-induced inhibition of neuronal potassium current.

Authors:  Jing-Xiang Yin; Rui-Fang Yang; Shumin Li; Alex O Renshaw; Yu-Long Li; Harold D Schultz; Matthew C Zimmerman
Journal:  Am J Physiol Cell Physiol       Date:  2010-01-20       Impact factor: 4.249

9.  Interleukin-10 inhibits angiotensin II-induced decrease in neuronal potassium current.

Authors:  Nan Jiang; Peng Shi; Fiona Desland; M Cristina Kitchen-Pareja; Colin Sumners
Journal:  Am J Physiol Cell Physiol       Date:  2013-02-20       Impact factor: 4.249

Review 10.  Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives.

Authors:  Shereeni J Veerasingham; Mohan K Raizada
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.